GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

No trades
See on Supercharts
Market capitalization
‪108.23 T‬ARS
‪3.01 T‬ARS
‪36.71 T‬ARS
Beta (1Y)
−0.04

About GSK plc


CEO
Emma N. Walmsley
Website
Headquarters
London
ISIN
ARDEUT110483
FIGI
BBG000CZGKJ6
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Check out other big names from the same industry as GSK.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
GSK6023693
GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
Yield to maturity
Maturity date
Apr 15, 2035
GSK6023691
GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027
Yield to maturity
Maturity date
Mar 12, 2027
GSK.GJ
GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
Yield to maturity
Maturity date
May 15, 2038
GSK3981911
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
Yield to maturity
Maturity date
Mar 18, 2043
GSK6023692
GlaxoSmithKline Capital Plc FRN 12-MAR-2027
Yield to maturity
Maturity date
Mar 12, 2027
GSK6023695
GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
Yield to maturity
Maturity date
Apr 15, 2030
XS168152035
GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029
Yield to maturity
Maturity date
Sep 12, 2029
XS182282979
GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030
Yield to maturity
Maturity date
May 21, 2030
XS217060907
GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035
Yield to maturity
Maturity date
May 12, 2035
US377372AN7
GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028
Yield to maturity
Maturity date
May 15, 2028
XS182282812
GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026
Yield to maturity
Maturity date
May 21, 2026

See all GSK bonds 

Curated watchlists where GSK is featured.